Quantum Biopharma (QNTM) Depreciation & Amortization (IS) (2019 - 2025)
Quantum Biopharma's Depreciation & Amortization (IS) history spans 7 years, with the latest figure at $129371.0 for Q4 2025.
- On a quarterly basis, Depreciation & Amortization (IS) rose 7.68% to $129371.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $545780.0, a 9.61% increase, with the full-year FY2025 number at $545780.0, up 11.25% from a year prior.
- Depreciation & Amortization (IS) hit $129371.0 in Q4 2025 for Quantum Biopharma, down from $145336.0 in the prior quarter.
- Over the last five years, Depreciation & Amortization (IS) for QNTM hit a ceiling of $1.1 million in Q1 2023 and a floor of $120141.0 in Q1 2024.
- Historically, Depreciation & Amortization (IS) has averaged $366998.2 across 5 years, with a median of $139098.0 in 2024.
- Biggest five-year swings in Depreciation & Amortization (IS): skyrocketed 36.99% in 2021 and later crashed 89.37% in 2024.
- Tracing QNTM's Depreciation & Amortization (IS) over 5 years: stood at $982353.0 in 2021, then grew by 12.09% to $1.1 million in 2022, then crashed by 86.67% to $146810.0 in 2023, then fell by 18.17% to $120141.0 in 2024, then rose by 7.68% to $129371.0 in 2025.
- Business Quant data shows Depreciation & Amortization (IS) for QNTM at $129371.0 in Q4 2025, $145336.0 in Q3 2025, and $141383.0 in Q2 2025.